Physician profile

Brian Joseph Snow

Orthopaedic Surgery · Mckinney, TX

NPI 1053536425

$4,939.25

in general payments reported to CMS, 2019-2025

47 companies · $542 in 2025

The $542 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).

See the full distribution for Orthopaedic Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,615.36

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $1,200.00 2022
Stryker Corporation $715.34 2019-2025 Cinchlock, T2 Alpha, Triathlon
Vericel Corporation $385.93 2019-2025 Maci
Depuy Synthes Sales INC. $280.21 2019-2025 Monovisc, Orthovisc
Zimmer Biomet Holdings, INC. $259.54 2019-2023 Mymobility Platform
Bioventus LLC $159.75 2022-2025 Durolane, Exogen Ultrasound Bone Healing System, Durolane
Pacira Therapeutics, INC. $156.95 2019-2021
Horizon Therapeutics Plc $151.98 2020-2022
Abbott Laboratories $140.32 2020-2024 Proclaim, Eterna
Medacta USA, INC. $118.98 2024-2025 Gmk Sphere
Pacira Pharmaceuticals Incorporated $112.77 2019-2024 Iovera, Zilretta, Exparel
Pylant Medical $89.12 2021-2024
Globus Medical, INC. $80.34 2025 Anthem
Orthofix Medical, INC. $73.22 2019-2023 Physio-Stim
Endo Pharmaceuticals INC. $72.16 2019-2021
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Total Joint Orthopedics, INC. $64.48 2025
Ferring Pharmaceuticals INC. $56.61 2025 Euflexxa
Linvatec Corporation $53.42 2025 Neospan, Biobrace 23mm
Ermi LLC $46.89 2019-2020
Fidia Pharma USA INC. $45.90 2021-2023 Hymovis, Triluron
Acera Surgical, INC. $42.26 2025 Restrata Wound Matrix
Baudax Bio INC. $41.51 2021
Siemens Medical Solutions USA, INC. $36.71 2023 Cios Spin
Spr Therapeutics, INC $35.72 2024 Sprint Pns System
Medtronic, INC. $32.98 2021-2022
Amgen INC. $32.75 2019-2020
Becton, Dickinson and Company $31.83 2025 Surgiphor
Bsn Medical INC $31.26 2022
Sanofi-Aventis U.S. LLC $31.09 2019
Assertio Therapeutics, INC. $30.39 2019-2020
Electronic Waveform Lab, INC. $29.99 2025
Arthrosurface Incorporated $29.35 2020
Medtronic USA, INC. $25.93 2019-2020
Theragen, INC. $24.74 2022
Innovation Technologies INC $24.27 2025 Irrisept
Nevro Corp. $22.93 2023 Senza
Heron Therapeutics, INC. $21.93 2023 Zynrelef
Kerecis Limited $19.56 2021
Kci USA, INC. $18.20 2021
Davol INC. $17.39 2021
Radius Health, INC. $17.00 2019
Skeletal Dynamics INC $15.22 2024 Align, Implate, Ijs
Cpm Medical Consultants, LLC $13.38 2022
Avanos Medical $13.37 2022
Integra Lifesciences Corporation $12.70 2022
Ibsa Pharma INC. $11.89 2020
Molnlycke Health Care US, LLC $10.99 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brian Joseph Snow

$4,939.25

in general payments reported 2019-2025

Years
2019-2025
Top company
Arthrex, INC.
Context
The $542 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).

https://glasscript.com/doctor/228804/brian-joseph-snow

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.